Related Experiment Video
Updated: Aug 9, 2026
10:37
Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
Psychologic Therapies for Irritable Bowel Syndrome
1Department of Psychological Medicine, University of Sydney, Nepean Hospital, PO Box 63, Penrith, New South Wales 2751, Australia. pboyce@mail.usyd.edu.au
Current Treatment Options in Gastroenterology
|July 27, 2001
Summary
Psychological therapies, including cognitive behavior therapy, are effective for irritable bowel syndrome (IBS) treatment. These approaches address the mind-gut connection to reduce symptoms and improve patient care.
Area of Science:
- Gastroenterology
- Psychology
- Psychosomatic Medicine
Background:
- Irritable bowel syndrome (IBS) treatment with pharmacologic agents often yields disappointing results.
- Psychological factors significantly influence IBS symptom presentation and healthcare-seeking behaviors.
- A biopsychosocial model integrating emotion and gut function is crucial for understanding IBS.
Purpose of the Study:
- To highlight the efficacy of psychological treatments for IBS.
- To emphasize the role of the biopsychosocial model in IBS management.
- To outline common elements of effective psychological interventions for IBS.
Main Methods:
- Review of psychologic treatments for IBS, including cognitive behavior therapy, hypnotherapy, and dynamic psychotherapy.
- Emphasis on the biopsychosocial model connecting emotion and gut function.
- Identification of common therapeutic elements: assessment, psychoeducation, support, and reassurance.
Main Results:
- Psychological therapies demonstrate effectiveness in managing IBS symptoms.
- Understanding the emotion-gut interaction is key to successful IBS treatment.
- Psychological interventions can mitigate symptom maintenance and inappropriate healthcare utilization.
Conclusions:
- Psychological treatments offer a viable and effective alternative or adjunct to pharmacologic therapies for IBS.
- Integrating psychological approaches into routine clinical practice can improve IBS patient outcomes.
- Addressing psychosocial factors is essential for comprehensive IBS management.
Related Concept Videos
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
01:21Drugs for Treatment of Constipation-Predominant IBS
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
01:17Irritable Bowel Syndrome I: Introduction
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
01:23Irritable Bowel Syndrome
DefinitionIrritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by recurrent combinations of abdominal pain, bloating, diarrhea, or constipation.Pathophysiology of irritable bowel syndromeIts pathophysiology is multifactorial, involving disturbances in motility, sensory processing, microbial balance, barrier integrity, and gut–brain communication. These mechanisms interact to produce symptoms that vary across IBS subtypes.Altered Motility PatternsDisordered...